In early tumor stages, M1 macrophages exert anti-tumor effects through pro-inflammatory cytokine production, such as TNF-α and IL-1β, and antigen presentation, yet their functions are often compromised by immunosuppressive mechanisms within the TME. Here, IL1B is linked to neoplasm.